In the spirit of the season, DI SCAN is taking a break. Coverage will resume Jan. 2.
In the spirit of the season, DI SCAN is taking a break. Coverage will resume Jan. 2.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.